Understanding and Improving Value Frameworks With Real-World Patient Outcomes
New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Read More
Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events
Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.
